Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks

NCT05119439 ↗

Phase 4 Terminated 23 enrolled Gynuity Health Projects Society of Family Planning · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study seeks to evaluate the efficacy, side effect profile and acceptability of a medical abortion regimen with mifepristone and two doses of 800 mcg misoprostol buccally at 71-77 and 78-84 days of gestation to further expand the evidence base for the most effective regimens in the late first trimester of pregnancy.

Timeline

Start: 2022-10-07
Primary completion: 2023-06-30
Completion: 2023-06-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Mifepristone	Small molecule	200 mg	—
Subject	Misoprostol	Other / unclassified	800 ug	Other

Indications

No indication recorded.